Douglas A. Treco, CEO & Chairman at Inozyme Pharma, Inc. (INZY), sold 8,819 shares at $0.89 ($8K) on 2025-04-02, disclosed to the SEC on 2025-04-03.
Open-market sale of $8k INZY by CEO & Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |